ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $18,000 | +50.0% | 950 | -4.8% | 0.00% | – |
| Q2 2019 | $12,000 | -14.3% | 998 | 0.0% | 0.00% | – |
| Q1 2019 | $14,000 | +27.3% | 998 | -11.8% | 0.00% | – |
| Q4 2018 | $11,000 | -38.9% | 1,131 | 0.0% | 0.00% | – |
| Q3 2018 | $18,000 | +12.5% | 1,131 | +13.3% | 0.00% | – |
| Q2 2018 | $16,000 | +14.3% | 998 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | 0.0% | 998 | -10.6% | 0.00% | – |
| Q4 2017 | $14,000 | +27.3% | 1,116 | +28.9% | 0.00% | – |
| Q3 2017 | $11,000 | +10.0% | 866 | +0.5% | 0.00% | – |
| Q2 2017 | $10,000 | -23.1% | 862 | +37.9% | 0.00% | – |
| Q1 2017 | $13,000 | +44.4% | 625 | +44.7% | 0.00% | – |
| Q4 2016 | $9,000 | +28.6% | 432 | +137.4% | 0.00% | – |
| Q3 2016 | $7,000 | +250.0% | 182 | +71.7% | 0.00% | – |
| Q2 2016 | $2,000 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
| Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
| Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
| NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
| SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
| Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
| Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
| PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
| PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
| BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |